1000s of Liberians in 'post-Ebola syndrome' study

2015-06-18 07:36
File: AP

File: AP

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Monrovia - Liberia launched a five-year study on Wednesday to unravel the mystery of the long-term health effects that plague Ebola survivors and assess how long they should go without sex.

The Partnership for Research on Ebola Vaccines in Liberia, a collaboration with the United States more commonly known by the acronym PREVAIL, is expected to enrol 1 500 survivors and 6 000 of their partners and family across the west African country.

"The clinical course of Ebola virus disease is reasonably well-understood, but we still have much to learn about the long-term health effects of the illness in those who recover," Anthony Fauci, of the US National Institutes of Health (NIH) said in a statement.

The epidemic killed more than 4 800 Liberians after spreading from Guinea in March last year but the country was given the all-clear on May 9 - 42 days after the last case was buried.

There has been little research on survivors, but the World Health Organisation (WHO) has acknowledged that many are experiencing crippling complications long after walking out of Ebola treatment units (ETUs).

Matshidiso Moeti, the WHO's head in Africa, told AFP in April Liberian survivors had been reporting a range of problems, including sight and hearing impairment, as part of a mystery condition referred to as "post-Ebola syndrome".

Investigators from the NIH's National Eye Institute (NEI), the John F Kennedy hospital in Monrovia and the Liberian government will collaborate on the research.

 'Many health complaints'

"We have realised that many survivors have come from the ETU complaining about health complications, but these complaints have not been documented and that seems like we are not concerned," Kasola Fallah, the study's chief researcher, told AFP in Monrovia.

The WHO announced in April that traces of Ebola had been found in the semen of a man six months after his recovery, recommending that survivors use condoms beyond the three-month period previously prescribed.

"It became apparent that lots of things about Ebola survivors have not been studied... That started to raise lots of questions about the disease," Fallah said.

All participants will undergo a medical history and physical and vision examination and have blood collected, while some will be asked to provide samples of sweat, tears, semen or cervical secretions.

Enrolment began with six survivors at the JFK on Wednesday, with sites across the country due to be added in the future.

"I am a survivor. Since I left the ETU I have been experiencing lots of health complaints," Luke Tarplah told AFP.

Trials on treatment

"Right now my head is strongly hurting. Sometimes it is my entire body. I am happy to be part of this study to know what are the reasons."

Participants will be asked to volunteer the names of up to five close contacts - family or sexual partners - who will also undergo examinations and blood tests before completing questionnaires detailing their contact with the survivor.

The research team will follow the Ebola survivors and their close contacts for up to five years, examining them and tracking health issues every six months.

In February, PREVAIL launched a clinical trial in Liberia on two experimental Ebola vaccines involving 1 500 participants which is ongoing.

The partnership is also working on trials on treatments in Liberia, Sierra Leone and the United States.

Read more on:    liberia  |  ebola  |  health  |  west africa

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.